- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/50 - Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
Patent holdings for IPC class C07D 233/50
Total number of patents in this class: 27
10-year publication summary
|
1
|
2
|
2
|
1
|
0
|
2
|
2
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2169 |
4 |
| BASF SE | 21303 |
2 |
| Cellix Bio Private Limited | 52 |
2 |
| Saint Louis University | 294 |
2 |
| Chengdu Kaoensi Science and Technology Co., Ltd. | 2 |
2 |
| Mindstate Design Labs, Inc. | 3 |
2 |
| F. Hoffmann-La Roche AG | 7836 |
1 |
| The Regents of the University of California | 20720 |
1 |
| Syngenta Participations AG | 1527 |
1 |
| Bayer Cropscience AG | 1846 |
1 |
| Albireo AB | 176 |
1 |
| Cellixbio Private Limited | 142 |
1 |
| Irm LLC | 126 |
1 |
| Novaled GmbH | 483 |
1 |
| Regents of the University of Minnesota | 2785 |
1 |
| FUJIFILM Wako Pure Chemical Corporation | 191 |
1 |
| The Royal Institution for The Advancement of Learning / McGill University | 713 |
1 |
| ExxonMobil Technology and Engineering Company | 1349 |
1 |
| Transdermal Sedation Solutions, LLC | 4 |
1 |
| Other owners | 0 |